Daily Archives: 13/11/2010

Watson Labs Rosuvastatin Zinc 505(b)(2)

On Oct 27, 2010, Watson confirmed the patent challenge on Rosuvastatin (Astrazeneca sued watson at Delaware). Watson has submitted new drug application under Section 505(b)(2) seeking approval to market rosuvastatin zinc 5, 10, 20 and 40 mg tablets (press release). On Nov … Continue reading

Posted in Daily interesting IP news, Patent case | Leave a comment

CI and Patent News: 13/11/2010

1) Forest Laboratories, Inc today announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic® (nebivolol) and Savella® (milnacipran HCl) in Canada with Janssen Pharmaceutica, NV and Janssen Pharmaceutical respectively, … Continue reading

Posted in Daily interesting IP news | Leave a comment